Therapies for peripheral joint disease in
psoriatic arthritis.
This report provides elemental information and data relating to the clinical trials on
Psoriatic Arthritis.
July 24, 2015 /PRNewswire-USNewswire/ -- For the first time, people with psoriasis and
psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis Foundation's (NPF) patient-centered research network called Citizen Pscientist.
WAIKOLOA, HAWAII - Joint pain arising in a patient with psoriasis is by no means necessarily due to
psoriatic arthritis.
ST ALBANS, England, July 15, 2010 /PRNewswire/ -- The Psoriasis and
Psoriatic Arthritis Alliance (PAPAA) has launched a new secure eCommerce site http://www.
Psoriatic arthritis (PsA) is classified as a spondyloarthropathy and characterized by synovitis, enthesitis, dactylitis, and spondylitis, usually manifesting in a person with skin and nail psoriasis.
BOUDRY, Switzerland -- Celgene International Sarl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from PALACE-1, the Company's first Phase III study in
psoriatic arthritis, at the American College of Rheumatology annual meeting in Washington, D.
July 15, 2015 /PRNewswire-USNewswire/ -- To increase the number of people with
psoriatic disease who are effectively treating their condition and improve their quality of life, the National Psoriasis Foundation and pharmaceutical company Pfizer will award up to $1 million in learning and change grants through a new grant program.
GOTHENBURG, SWEDEN -- In patients with both plaque psoriasis and
psoriatic arthritis, initial treatment with etanercept at 50 mg twice weekly resulted in faster clearance of skin lesions than 50 mg once weekly.
Data signalling that Enbrel(R) (etanercept) can improve the quality of life for people with psoriasis and
psoriatic arthritis were presented at the 18th Congress of the European Academy of Dermatology and Venereology (EADV), as Enbrel(R) (etanercept) reached its five-year anniversary since its approval in Europe as a treatment for psoriasis.
Through collaborative research of international working groups, classification criteria for
psoriatic arthritis (PsA) and ankylosing spondylitis (AS) have been developed or are being refined to aid characterization and diagnosis of SpAs and aid in research.
com/research/sccvjf/global_
psoriatic) has announced the addition of the "Global
Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2012" report to their offering.
